Redx Pharma (REDX)

Sector:

Pharma and Biotech

12.75p
   
  • Change Today:
    -0.75p
  • 52 Week High: 36.00
  • 52 Week Low: 4.25
  • Currency: UK Pounds
  • Shares Issued: 388.99m
  • Volume: 839,827
  • Market Cap: £49.60m
  • RiskGrade: 278

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
97.31% below the market average97.31% below the market average97.31% below the market average97.31% below the market average97.31% below the market average
94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
45.79% above the market average45.79% above the market average45.79% above the market average45.79% above the market average45.79% above the market average
24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average
Price Book Ratio
95.23% below the market average95.23% below the market average95.23% below the market average95.23% below the market average95.23% below the market average
79.59% below the sector average79.59% below the sector average79.59% below the sector average79.59% below the sector average79.59% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
96.08% below the market average96.08% below the market average96.08% below the market average96.08% below the market average96.08% below the market average
92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average92.98% below the sector average
Price Chg 3m
85.52% below the market average85.52% below the market average85.52% below the market average85.52% below the market average85.52% below the market average
40.35% below the sector average40.35% below the sector average40.35% below the sector average40.35% below the sector average40.35% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
31.1% below the market average31.1% below the market average31.1% below the market average31.1% below the market average31.1% below the market average
20.75% below the sector average20.75% below the sector average20.75% below the sector average20.75% below the sector average20.75% below the sector average
Momentum 20
65.55% below the market average65.55% below the market average65.55% below the market average65.55% below the market average65.55% below the market average
73.58% below the sector average73.58% below the sector average73.58% below the sector average73.58% below the sector average73.58% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
89.39% below the market average89.39% below the market average89.39% below the market average89.39% below the market average89.39% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
83.14% below the market average83.14% below the market average83.14% below the market average83.14% below the market average83.14% below the market average
59.26% below the sector average59.26% below the sector average59.26% below the sector average59.26% below the sector average59.26% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
59.37% below the market average59.37% below the market average59.37% below the market average59.37% below the market average59.37% below the market average
22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average
Operating Profit Loss
90.97% below the market average90.97% below the market average90.97% below the market average90.97% below the market average90.97% below the market average
85.19% below the sector average85.19% below the sector average85.19% below the sector average85.19% below the sector average85.19% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
4.99% below the market average4.99% below the market average4.99% below the market average4.99% below the market average4.99% below the market average
23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average
Cash
25.30% above the market average25.30% above the market average25.30% above the market average25.30% above the market average25.30% above the market average
37.04% above the sector average37.04% above the sector average37.04% above the sector average37.04% above the sector average37.04% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
44.24% below the market average44.24% below the market average44.24% below the market average44.24% below the market average44.24% below the market average
54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
40.45% above the market average40.45% above the market average40.45% above the market average40.45% above the market average40.45% above the market average
61.90% above the sector average61.90% above the sector average61.90% above the sector average61.90% above the sector average61.90% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Redx Pharma Market Data

Currency UK Pounds
Share Price 12.75p
Change Today -0.75p
% Change -5.56 %
52 Week High 36.00
52 Week Low 4.25
Volume 839,827
Shares Issued 388.99m
Market Cap £49.60m
RiskGrade 278

Redx Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
60.74% below the market average60.74% below the market average60.74% below the market average60.74% below the market average60.74% below the market average
84.91% below the sector average84.91% below the sector average84.91% below the sector average84.91% below the sector average84.91% below the sector average
Price Trend
88.54% below the market average88.54% below the market average88.54% below the market average88.54% below the market average88.54% below the market average
57.89% below the sector average57.89% below the sector average57.89% below the sector average57.89% below the sector average57.89% below the sector average
Income Not Available
Growth
28.46% below the market average28.46% below the market average28.46% below the market average28.46% below the market average28.46% below the market average
45.95% below the sector average45.95% below the sector average45.95% below the sector average45.95% below the sector average45.95% below the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Redx Pharma Dividends

No dividends found

Trades for 18-Apr-2024

Time Volume / Share Price
16:27 125,000 @ 12.00p
16:28 25,000 @ 12.10p
16:24 15 @ 13.50p
16:24 30 @ 12.00p
16:24 88 @ 12.00p

Top of Page